Incidence and Clinical Behavior of Papillary Thyroid Carcinoma in Renal Allograft Recipients: A Single Center Experience

Transplantation Proceedings

Volumn 40, Issue 10, 2008, Pages 3751-3754

  Lee, J ^a   Jeong, J J ^b   Lee, Y S ^b   Nam, K H ^b   Chang, H S ^b   Chung, W Y ^b   Soh, E Y ^a   Kim, Y S ^b   Park, C S ^b  

^a Ajou University Medical CentSuwon   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; OKT 3; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CARCINOMA; CHILD; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; INCIDENTALOMA; KIDNEY ALLOGRAFT; KOREA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX RATIO; THYROID GLAND; THYROID PAPILLARY CARCINOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES; THYROID HORMONES; THYROID NEOPLASMS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 57549101042     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.07.127     Document Type: Article

References (27)

1. Penn I., Hammond W., Brettschneider L., et al. Malignant lymphomas in transplantation patients. Transplant Proc 1 (1969) 106
2. London N.J., Farmery S.M., Will E.J., et al. Risk of neoplasia in renal transplant patients. Lancet 346 (1995) 403
3. Penn I. Second malignant neoplasms associated with immunosuppressive medications. Cancer 37 (1976) 1024
4. Winkelhorst J.T., Brokelman W.J., Tiggeler R.G., et al. Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol 27 (2001) 409
5. Veroux M., Puliatti C., Fiamingo P., et al. Early de novo malignancies after kidney transplantation. Transplant Proc 36 (2004) 718
6. Brunner F.P., Landais P., and Selwood N.H. Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association. Nephrol Dial Transplant 10 (1995) 74
7. Sheil A.G. Cancer after transplantation. World J Surg 10 (1986) 389
8. Fahey III T.J., Reeve T.S., and Delbridge L. Increasing incidence and changing presentation of thyroid cancer over a 30-year period. Br J Surg 82 (1995) 518
9. Franceschi S., and La Vecchia C. Thyroid cancer. Cancer Surv 19-20 (1994) 393
10. Nemes B., Zalatnai A., Podder H., et al. Papillary microcarcinoma of the thyroid gland in renal transplant patients. Pathol Oncol Res 6 (2000) 72
11. Korea Central Cancer Registry Working Group. Korea Cancer Statistics: 1996 Incidence (2004), Department of Disease Control and Prevention Services. National Health Insurance Cooperation and National Cancer Institute, Seoul, Korea
12. In: Greene F.L., Page L., Fleming I.D., et al. (Eds). AJCC Cancer Staging Handbook: TNM Classification of Malignant Tumors. 6th Ed. (2002), Springer-Verlag, New York 77
13. Burnet F.M. Immunological aspects of malignant disease. Lancet 1 (1967) 1171
14. Keast D. Immunosurveillance and cancer. Lancet 2 (1970) 710
15. Schwartz R.S. Immunoregulation, oncogenic viruses, and malignant lymphomas. Lancet 1 (1972) 1266
16. Suzuki T., Takano Y., Yamashita K., et al. A possible role for Epstein-Barr virus in tumorigenesis after immunosuppression in cases of renal transplantation. J Cancer Res Clin Oncol 119 (1993) 627
17. Penn I. Cancers following cyclosporine therapy. Transplantation 43 (1987) 32
18. Penn I. Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet 162 (1986) 603
19. First M.R., and Peddi V.R. Malignancies complicating organ transplantation. Transplant Proc 30 (1998) 2768
20. Nafar M., Einollahi B., Hemati K., et al. Development of malignancy following living donor kidney transplantation. Transplant Proc 37 (2005) 3065
21. Pedotti P., Cardillo M., Rossini G., et al. Incidence of cancer after kidney transplant: results from the North Italy transplant program. Transplantation 76 (2003) 1448
22. Sheil A.G. Malignancy in organ transplant recipients. Transplant Proc 28 (1996) 1162
23. Wang C.X., Liu L.S., Chen L.Z., et al. Characteristics of neoplasm occurrence and the therapeutic effect of sirolimus in South Chinese kidney transplant recipients. Transplant Proc 38 (2006) 3536
24. Pond F., Serpell J.W., Webster A., et al. Thyroid cancer in the renal transplant population: epidemiological study. ANZ J Surg 75 (2005) 106
25. Samhan M., Al-Mousawi M., Donia F., et al. Malignancy in renal recipients. Transplant Proc 37 (2005) 3068
26. Hoshida Y., and Aozasa K. Malignancies in organ transplant recipients. Pathol Int 52 (2004) 649
27. Kasiske B.L., Snyder J.J., Gilbertson D.T., et al. Cancer after kidney transplantation in the United States. Am J Transplant 4 (2004) 905